Dual antiplatelet therapy is recommended after coronary stenting to prevent thrombotic complications, yet the benefits and risks of treatment beyond 1 year are uncertain
The PRODIGY trial 45 assessed durations of dual antiplatelet therapy both
A drug-eluting stent, or DES, is a small, metal mesh tube placed in a blocked coronary
12 Drug-eluting stents have a slower endothelialization In the past, several RCTs were conducted to prove the safety and efficacy of short-term DAPT in a patient with different stents
Perioperative risk stratification in these patients is challenging and should take into account many individual clinical and anatomic variables, along with the intrinsic The trial enrolled 2,993 patients who underwent PCI and received a drug-eluting stent at 33 medical centers in South Korea
Dual antiplatelet therapy (DAPT), defined as the use of a P2Y12 receptor inhibitor (clopidogrel, ticagrelor or prasugrel) and aspirin, is required after percutaneous coronary intervention (PCI) with drug-eluting stents (DES)
So… does this mean that at one year and one day after a or 6-12 months duration of anti-platelet therapy followed by 0-6 months of aspirin alone after drug-eluting stent placement procedure
JAMA 2007 ;297: 159 - 168 Crossref Bare-metal stent: triple therapy with warfarin, low-dose aspirin, and clopidogrel in month 1; combination of warfarin with single antiplatelet agent in months 2 and 3 Patients who have had heart attacks, long stent lengths, etc
[Google Scholar] Drug-eluting stent An example of a drug-eluting stent
2% in My question remains: 1
Eur Heart J
Clopidogrel, a pro-drug, is metabolized to active metabolite in the liver in a two-step process by CYP3A4/3A5 and CYP2B6/1A2/2C9/2C19 esterases
[11-06-2015] A U
• Retired in Cupertino -- Recommendation after drug-eluting stent is one year of Plavix and aspirin, and aspirin thereafter